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A homogenate of purified chromaffin cells was fractionated, after removal of the nuclear fraction, by sucrose density 
gradient ultracentrifugation. The presence and subcellular localization of low molecular mass GTP-binding proteins was 
explored by incubation of blots of proteins from different subcellular fractions with [@P]GTP in the presence of MgZ’. 
The fractions enriched in intact chromaffin granule markers, i.e. catecholamines, chromogranin A, chromogranin B and 
cytochrome b-561 were also enriched in labelled GTP-binding proteins. Two major labelled components of 23 and 29 
kDa were rapidly detected by autoradiography. Traces of 26 and 27 kDa components were also present. These compo- 
nents were detectable in both plasma and granule membranes. In addition to these components, the cytosolic fraction 
contained another GTP-binding protein of about 20 kDa. Binding of [c@P]GTP was specific and dependent on MgZ+. 
By analogy to the findings reported in non-mammalian systems, the observations described here suggest he involvement 
of low molecular mass GTP-binding proteins in the chromaffin cell secretory process. 
GTP-binding protein; Chromaffin granule; Secretory process; Gene product, ras 
1. INTRODUCTION 
Several families of GTP-binding proteins have 
been described [l]: (i) the soluble factors which 
participate in protein synthesis 121; (ii) the tubulin 
subunits [3]; (iii) the well known oligomeric G- 
proteins [4]; and (iv) the recently found low 
molecular mass GTP-binding proteins which have 
been implicated in secretion [5]. The importance of 
this latter group has been demonstrated in yeast 
Saccharomyces cerevisiae using specific mutations 
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affecting various steps of the secretory pathway’ 
[6-81. A lethal mutation of the YPTl gene coding 
for a 23 kDa GTP-binding protein (YPTlp) caus- 
ed membranes and vesicles to accumulate, 
disrupted microtubule organization and decreased 
secretion [6,7]. YPTlp appears to reside in the 
Golgi apparatus [6]. Mutations in SEC4 gene 
coding for a 23.5 kDa GTP-binding protein 
(SEC4p) abolished the late steps of secretion [8]. 
SEC4p is associated not only with the plasma 
membrane but also with secretory vesicles 191. 
These as well as other proteins are all ras-related 
proteins [lO,ll]. 
Two techniques have been used to detect GTP- 
binding proteins. The most widely used technique 
involves ADP-ribosylation by toxins derived from 
V. cholerae (G, and transducin) and B. pertussis 
(Gi, G, and transducin) [4]. The second method in- 
volves the labelling with [w”P]GTP on 
nitrocellulose blots of proteins separated by SDS- 
PAGE. This latter approach as been used to 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 127 
Volume 247, number 1 FEBS LETTERS April 1989 
detect ras p21 proteins [12] as well as other low 
molecular mass GTP-binding proteins present in 
mouse brain, lung, kidney and spleen [ 131, 
NIH3T3 cells [13], human neutrophils [ 141 and 
human platelet membranes [151. 
In the present work, we investigate the presence 
and localization of low molecular mass GTP- 
binding proteins in purified bovine adrenal 
chromaffin cells. A preliminary account of the 
results has been presented elsewhere [16]. 
2. MATERIALS AND METHODS 
2.1. Materials 
[cr-32P]GTP (3700 Ci/mmol) was purchased from NEN (Du 
Pont Canada Inc., Mississauga, Ont., Canada). Nitrocellulose 
membranes (0.2/m pore size) were obtained from Technical 
Marketing (Ottawa, Ontario, Canada). ATP, GMP, GDP, 
GTP and GTP-7-S were purchased from Sigma Chemical Co. 
(St. Louis, MO, USA). Protein standards for electrophoresis, 
alkaline phosphatase conjugated anti-rabbit IgG and the 
alkaline phosphatase color development reagents were from 
Bio-Rad Laboratories (Mississauga, Ont., Canada). Rabbit 
polyclonal antibodies were generous gifts from Dr P.J. Flem- 
ing, Georgetown University Medical Center, Washington, DC, 
USA (anti-cytochrome b-561) and Dr H. Winkler, University of 
Innsbruck, Austria (anti-chromogranin A and anti- 
chromogranin B). 
2.2. Subcellular fractionation of chromaffin cells 
Bovine chromaffin cells isolated as described previously [17] 
were further purified on Percoll density gradients [18]. A 50 x 
lo6 cell pellet was resuspended in 1.5 ml of a buffer containing 
0.25 M sucrose, 1 mM EGTA, 0.2 mM PMSF and 3 mM 
Hepes, pH 7.0 (4’C). The cell suspension was then homoge- 
nized in a 3 ml Potter-Elvehjem type tissue grinder using 20 up 
and down strokes at 2700 rpm (4°C). The homogenate was cen- 
trifuged at 12000 x g (Beckman microfuge) for 15 s to sediment 
the nuclear fraction. The supernatant obtained (Sl) was then 
layered over a sucrose gradient formed by twenty-one 0.4 ml 
layers of sucrose of increasing concentrations (20 to 60%, w/w, 
at 2% steps, buffered with 1 mM EGTA, 0.2 mM PMSF and 
3 mM Hepes, pH 7.0) prepared according to Luthe [19]. The 
gradient was centrifuged for 15 h at 120000 x g in a Beckman 
SW28.1 rotor. Nineteen fractions (0.5 ml) were collected from 
top to bottom and then stored at -80°C until further use. 
2.3. SDS-PAGE, blotting of proteins and immunostaining 
Protein samples were subjected to electrophoresis using a 
highly porous SDS-PAGE system recently developed in our 
laboratory [20]. The proteins resolved on gel were transferred 
to nitrocellulose sheets electrophoretically as described 
previously [20]. The antibodies (anti-cytochrome b-561, anti- 
chromogranin A and anti-chromogranin B) were used at a dilu- 
tion of 1: 10000 on separate blots (1 h incubation) [21]. 
Alkaline phosphatase conjugated anti-rabbit IgG (1: 3000) was 
used as second antibody. 
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2.4. Incubation of blots with ~cu-~~P]GTP 
Nitrocellulose blots were incubated for 30 min at room 
temperature in a buffer containing 0.3% (w/v) bovine serum 
albumin (BSA), 0.25% (w/v) Tween-20, 2 mM DTT, 50pM 
MgClz, 20 mM Tris-HCI, pH 7.7, and 5 &i of 
[~Y-~*P]GTP/IS ml (final concentration 1 nM) [12,16]. Excep- 
tions to this procedure are indicated in the figure legends. After 
washing twice in the same buffer without BSA and [cu-~*P]GTP, 
blots were air dried and bound 32P was detected by 
autoradiography (16-48 h at - 8O’C). 
2.5. Other methods 
Catecholamines were measured using the trihydroxyindole 
fluorometric method of Anton and Sayre [22]. The method of 
Markwell et al. [23] was used to determine protein concen- 
trations. 
3. RESULTS AND DISCUSSION 
Upon centrifugation of the chromaffin cell Sl 
supernatant on sucrose density gradients, 19 frac- 
tions were collected from top to bottom. Protein 
and catecholamine contents were determined for 
each fraction (fig. 1A). Catecholamine mea- 
surements howed that fractions 14 to 19 contained 
the bulk of intact chromaffin granules. These frac- 
tions also represent he second main protein peak 
of the gradient corresponding to the denser sucrose 
concentrations (1.6 to 2.0 M). Free catecholamines 
released from granules broken during the 
homogenization procedure were also detected at 
the top of the gradient (fractions l-3) within the 
cytosol fraction. 
Fig.lB shows the amido black stained polypep- 
tide pattern of each of the 19 fractions after SDS- 
PAGE and electrotransfer. Immunoblottings were 
also carried out to characterize the sucrose gra- 
dient fractionation using rabbit polyclonal an- 
tibodies raised against various chromaffin granule 
markers. The corresponding immunoblots obtain- 
ed with two chromaffin granule soluble protein 
markers, chromogranin A (SO kDa) and 
chromogranin B (117.5 kDa) and the granule 
membrane marker cytochrome b-561 (26 kDa) are 
shown in fig. 1C. The smaller molecular mass 
bands which cross-react with the antibodies against 
chromogranin B (fig. lC, top) and chromogranin A 
(fig.lC, middle) are proteolytic derivatives of the 
precursors of molecular mass 117500 Da 
(chromogranin B) and 80 kDa (chromogranin A), 
respectively [24]. The higher molecular mass im- 
munoreactive band observed with the anti- 
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Fig. 1. Characterization of the fractions obtained upon sucrose 
density centrifugation. (A) Catecholamines (R) and protein ( q ) 
contents of the 19 fractions collected. Aliquots (25 ~1) of the 
fractions were also separated by SDS-PAGE and transferred on 
nitrocellulose membranes (B/Z). (B) Polypeptide patterns 
visualized by amido black staining. (C) Immunostainings with 
antibodies against chromogranin B (117.5 kDa) (top), 
chromogranin A (80 kDa) (middle) and cytochrome b-561 
(26 kDa) (bottom). The arrows indicate the position of the 
marker considered. 
chromogranin A antibody (fig.lC, middle) is 
probably a non-specific staining. 
Upon incubation of the blots with [(Y-‘*P]GTP 
under the conditions described in section 2, a fami- 
ly of low molecular mass proteins was detected by 
autoradiography in chromaffin cell subcellular 
fractions (fig.2). The fractions 14-19 which were 
Fig.2. Detection by autoradiography of the low molecular mass 
GTP-binding proteins on blots of 19 gradient fractions from the 
same experiment described in fig. 1. The 20 kDa component of 
the cytosolic fraction (fractions 1-3) was observed upon longer 
exposure (inset). 
enriched in intact chromaffin granule markers, i.e. 
catecholamines, chromogranin A, chromogranin B 
and cytochrome b-561 were also enriched in 23 and 
29 kDa GTP-binding proteins (fig.2). Longer ex- 
posure of the autoradiogram also reveals the 
presence of traces of 26 and 27 kDa labelled 
polypeptides. Thus, at least 4 labelled components 
(23, 26, 27 and 29 kDa) were detected upon 
monodimensional electrophoresis. These GTP- 
binding proteins were also present in fractions 4-7 
corresponding to chromaffin granule membranes 
as indicated by immunostaining with anti- 
cytochrome b-561 (fig.lC, bottom). In this sucrose 
gradient, the plasma membrane was found to cor- 
respond to the fractions 3 and 4. Indeed these 
fractions contain the cY-bungarotoxin-binding 
component as detected by ‘*‘I-a-bungarotoxin 
overlay technique (Doucet and Trifar6, in prepara- 
tion). No such labelled binding site is present in the 
fractions 5 to 19. This observation rules out the 
possibility of cross contamination for instance of 
the chromaffin granule fractions (14-19) by the 
plasma membrane. The GTP-binding proteins 
described above were also present in chromaffin 
cell plasma membranes purified on polycationic 
beads as described by Fournier and Trifar6 [21] 
(data not shown). In addition to these labelled 
polypeptides, the cytosolic fraction at the top of 
the gradient (fractions l-3) which was enriched in 
free catecholamines and chromogranins A and B, 
contained another GTP-binding protein of about 
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20 kDa (fig.2 inset). The 29 kDa GTP-binding 
protein is likely to correspond to the 27 kDa (G, 
27) GTP-binding protein detected in platelets, 
brain, adrenal gland and other tissues using 2 pM 
MgClz in the incubation medium [15]. The label- 
ling of these polypeptides was abolished com- 
pletely in the presence of 5 mM CDTA (data not 
shown). 
Binding of [a-32P]GTP to cytosolic components 
was specific in that it was unaffected by the addi- 
tion of 10pM ATP and only partly blocked by 
10pM GMP (fig.3B,C). However, 10,~M GDP, 
GTP-T-S or GTP completely abolished binding 
(fig.3D-F). 
In mast cells [25] and human neutrophils [26] in- 
tracellular addition of GTP-y-S is an effective 
stimulus to induce exocytosis. In permeabilized 
cultured cells, Gpp(NH)p, a non-hydrolyzable 
analogue of GTP, also produces stimulation of the 
ATP-dependent , Ca2+-independent release of 
catecholamines [27]. However, in freshly isolated 
bovine chromaffin cells, GTP-7-S inhibits 
Ca2+-dependent exocytosis [28]. According to 
Bourne’s model [5], the hydrolysis-resistant GTP 
analog GTP-y-S should block vesicle transport by 
preventing the vesicle-XGTP+YZ complex to set 
the stage for fusion [5]. In the related PC12 cells, 
microinjection of the 21 kDa ras proto-oncogene 
product induces NGF-like differentiation [29]. 
Fig.3. Specificity of nucleotide binding to chromaffin cell 
soluble proteins. Aliquots (30rg) of chromaffin cell cytosol 
fraction were electrophoresed and blotted onto nitrocellulose. 
Membrane strips were incubated with 1 nM [rr-“‘P]GTP and 
50 PM MgCl in the absence or presence of different nucleotides. 
Autoradiograms were obtained after the following treatments: 
(a) no nucleotide added; (b) IO pM GMP; (c) 10 PM ATP; (d) 
10~M GDP; (e) lO/tM GTP-7-S; (f) 1OpM GTP. 
Moreover, microinjection of anti-ras antibodies 
can block the NGF-induced differentiation [30]. 
To our knowledge, the study described here is 
the first demonstration of the presence of low 
molecular mass GTP-binding proteins (23- 
29 kDa) in mammalian secretory vesicles. The 
GTP-binding proteins present in membranes from 
chromaffin granules and plasma membranes how 
a very similar subcellular localization as the 
Bordetellapertussis ubstrates (39, 40 and 41 kDa) 
recently found in chromaffin cells [31]. These 
findings and the observations described above in- 
dicate that regulation of biological processes by 
GTP-binding proteins in chromaffin cells is indeed 
very complex. Among these processes and given 
the subcellular localization of these proteins, the 
control of exocytosis is likely to be affected (see 
[51). 
Whether the products of the ras gene superfami- 
ly [6-l l] are related to the group of low molecular 
mass GTP-binding proteins described in these 
studies remains to be determined. 
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